Robin Clark to Schizophrenia
This is a "connection" page, showing publications Robin Clark has written about Schizophrenia.
Connection Strength
1.365
-
Mueser KT, Glynn SM, Cather C, Zarate R, Fox L, Feldman J, Wolfe R, Clark RE. Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial. Addict Behav. 2009 Oct; 34(10):867-77.
Score: 0.271
-
Clark RE, Xie H, Brunette MF. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. J Clin Psychiatry. 2004 Feb; 65(2):151-5.
Score: 0.189
-
Clark RE, Mueser KT. Progress in research on dual disorders. Br J Psychiatry. 2003 Nov; 183:377-8.
Score: 0.186
-
Clark RE, Bartels SJ, Mellman TA, Peacock WJ. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy. Schizophr Bull. 2002; 28(1):75-84.
Score: 0.164
-
Hugunin J, Chen Q, Baek J, Clark RE, Lapane KL, Ulbricht CM. Quality of Nursing Homes Admitting Working-Age Adults With Serious Mental Illness. Psychiatr Serv. 2022 07; 73(7):745-751.
Score: 0.163
-
Hugunin J, Yuan Y, Baek J, Clark RE, Rothschild AJ, Lapane KL, Ulbricht CM. Characteristics of Working-Age Adults With Schizophrenia Newly Admitted to Nursing Homes. J Am Med Dir Assoc. 2022 07; 23(7):1227-1235.e3.
Score: 0.163
-
Latimer EA, Naidu A, Moodie EE, Clark RE, Malla AK, Tamblyn R, Wynant W. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals. Psychiatr Serv. 2014 Oct; 65(10):1210-7.
Score: 0.099
-
Mueser KT, Glynn SM, Cather C, Xie H, Zarate R, Smith LF, Clark RE, Gottlieb JD, Wolfe R, Feldman J. A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders. Schizophr Bull. 2013 May; 39(3):658-72.
Score: 0.082
-
Bartels SJ, Clark RE, Peacock WJ, Dums AR, Pratt SI. Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. Am J Geriatr Psychiatry. 2003 Nov-Dec; 11(6):648-57.
Score: 0.047